Raymond James Financial
LH icon

Raymond James Financial’s Labcorp LH Stock Holding History

Raymond James Financial’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.9M Buy
113,856
+10,515
+10% +$2.76M 0.01% 1240
2026
Q1 		$27.6M Sell
103,341
-13,754
-12% -$3.72M 0.01% 1249
2025
Q4 		$29.4M Sell
117,095
-15,569
-12% -$4.13M 0.01% 1181
2025
Q3 		$38.1M Sell
132,664
-26,572
-17% -$7.12M 0.01% 978
2025
Q2 		$41.8M Buy
159,236
+7,982
+5% +$1.94M 0.01% 866
2025
Q1 		$35.2M Buy
151,254
+3,952
+3% +$959K 0.01% 922
2024
Q4 		$33.8M Buy
+147,302
New +$33.8M 0.01% 955

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Raymond James Financial's LH Position: Q2 2026 in Review

Raymond James Financial increased its Labcorp (LH) stake by 10% in Q2 2026, buying an estimated $2.76M and bringing the position to 113,856 shares worth $31.9M. The position accounts for 0.01% of the portfolio, ranked #1240.

Raymond James Financial first reported a position in LH in Q4 2024 and has held it in 7 quarters since. The position peaked at $41.8M in Q2 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Raymond James Financial held 113,856 shares of Labcorp worth $31.9M as of Q2 2026.
  • Raymond James Financial bought 10,515 Labcorp shares in Q2 2026, an estimated $2.76M.
  • Labcorp made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1240 holding.
  • Raymond James Financial first reported a position in Labcorp in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Labcorp position peaked at $41.8M in Q2 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.